The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Mortality From Ischemic Heart Disease: Analysis of Data From the World Health Organization and Coronary Artery Disease Risk Factors From NCD Risk Factor Collaboration
Open accessAbstract
Background: Ischemic heart disease (IHD) has been considered the top cause of mortality globally. However, countries differ in their rates and there have been changes over time. Methods and Results: We analyzed mortality data submitted to the World Health Organization from 2005 to 2015 by individual countries. We explored patterns in relationships with age, sex, and income and calculated age-standardized mortality rates for each country in addition to crude death rates. In 5 illustrative countries which provided detailed data, we analyzed trends of mortality from IHD and 3 noncommunicable diseases (lung cancer, stroke, and chronic lower respiratory tract diseases) and examined the simultaneous trends in important cardiovascular risk factors. Russia, United States, and Ukraine had the largest absolute numbers of deaths among the countries that provided data. Among 5 illustrative countries (United Kingdom, United States, Brazil, Kazakhstan, and Ukraine), IHD was the top cause of death, but mortality from IHD has progressively decreased from 2005 to 2015. Age-standardized IHD mortality rates per 100 000 people per year were much higher in Ukraine (324) and Kazakhstan (97) than in United States (60), Brazil (54), and the United Kingdom (46), with much less difference in other causes of death. All 5 countries showed a progressive decline in IHD mortality, with a decline in smoking and hypertension and in all cases a rise in obesity and type II diabetes mellitus. Conclusions: IHD remains the single largest cause of death in countries of all income groups. Rates are different between countries and are falling in most countries, indicating great potential for further gains. On the horizon, future improvements may become curtailed by increasing hypertension in some developing countries and more importantly global growth in obesity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Despite advancements in clinical management, MI and ischemic cardiomyopathy are among the leading causes of heart failure, associated morbidity, and death worldwide 3,4 and continue to impose staggering financial burden on healthcare systems 3,5-8 .”
From Targeting the Immune-Fibrosis Axis in Myocardial Infarction and Heart Failure (2022) · cites this paper as [5]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Foreman, K. J., Marquez, N., Dolgert, A. J., Fukutaki, K. G., Fullman, N., McGaughey, M., Pletcher, M. A., Smith, A. E., Tang, K., Yuan, C.-W., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)31694-5 · Cited by 3,154
Use of mass media campaigns to change health behaviour
Wakefield, M. A., Loken, B., & Hornik, R. C. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60809-4 · Cited by 2,485
AGE STANDARDIZATION OF RATES: A NEW WHO STANDARD
Ahmad, O. B., Boschi-Pinto, C., López, A. D., Murray, C. J. L., Lozano, R., & Inoue, M. (2000) · Cited by 1,793
Global Health Observatory Data Repository
Vardell, E. (2020) · Medical Reference Services Quarterly · doi:10.1080/02763869.2019.1693231 · Cited by 1,575
Finegold, J. A., Asaria, P., & Francis, D. P. (2012) · International Journal of Cardiology · doi:10.1016/j.ijcard.2012.10.046 · Cited by 880
Self-citationThe Coronary Artery Disease (C4D) Genetics Consortium (2011) · Nature Genetics · doi:10.1038/ng.782 · Cited by 674
Cardiovascular Health in Brazil
Ribeiro, A. L. P., Duncan, B. B., Brant, L. C. C., Lotufo, P. A., Mill, J. G., & Barreto, S. M. (2016) · Circulation · doi:10.1161/circulationaha.114.008727 · Cited by 374
Steel, N., Ford, J. A., Newton, J. N., Davis, A. C., Vos, T., Naghavi, M., Glenn, S., Hughes, A. J., Dalton, A. M., Stockton, D., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)32207-4 · Cited by 275
Nowbar, A. N., Howard, J. P., Finegold, J. A., Asaria, P., & Francis, D. P. (2014) · International Journal of Cardiology · doi:10.1016/j.ijcard.2014.04.096 · Cited by 157
Self-citationCentral Asia — twenty-five years after the breakup of the USSR
Batsaikhan, U., & Dąbrowski, M. (2017) · Russian Journal of Economics · doi:10.1016/j.ruje.2017.09.005 · Cited by 148
Cited by
Sorted by citations
Items 201–300 of 865
Targeting the Immune-Fibrosis Axis in Myocardial Infarction and Heart Failure
Amrute, J. M., Luo, X., Penna, V., Bredemeyer, A., Yamawaki, T., Heo, G. S., Shi, S., Koenig, A., Yang, S., Kadyrov, F., et al. (2022) · bioRxiv · doi:10.1101/2022.10.17.512579 · Cited by 14
Takahashi, N., Dohi, T., Endo, H., Funamizu, T., Wada, H., Doi, S., Kato, Y., Ogita, M., Okai, I., Iwata, H., et al. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9041033 · Cited by 14
Qamar, A., Zhao, J., Xu, L., McLeod, P., Huang, X., Jiang, J., Liu, W., Haig, A. R., & Zhang, Z. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222011038 · Cited by 14
Assessment of Postoperative Outcomes of Spine Fusion Patients With History of Cardiac Disease
Ahmad, W., Fernandez, L., Bell, J., Krol, O., Kummer, N., Passfall, L., Naessig, S., Pierce, K., Tretiakov, P., Moattari, K., et al. (2022) · Journal of the American Academy of Orthopaedic Surgeons · doi:10.5435/jaaos-d-21-00850 · Cited by 14
Machine Learning and Artificial Neural Network for Predicting Heart Failure Risk
Rahman, P., Rifat, A., Chy, M. I., Khan, M. M., Masud, M., & Aljahdali, S. (2022) · Computer Systems Science and Engineering · doi:10.32604/csse.2023.021469 · Cited by 14
Chiastra, C., Zuin, M., Rigatelli, G., D’Ascenzo, F., Ferrari, G. M. D., Collet, C. A., Chatzizisis, Y. S., Gallo, D., & Morbiducci, U. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1216796 · Cited by 14
Ortiz‐Prado, E., Izquierdo‐Condoy, J. S., Fernández-Naranjo, R., Vásconez-González, J., Cevallos, L. C., González, A. C., Morales-Lapo, E., Guerrero-Castillo, G. S., Duque, E., Rosero, M. G. D., et al. (2023) · PLoS ONE · doi:10.1371/journal.pone.0295586 · Cited by 14
An eNAMPT-neutralizing mAb reduces post-infarct myocardial fibrosis and left ventricular dysfunction
Liu, Z., Sammani, S., Barber, C. J., Kempf, C. L., Li, F., Yang, Z., Bermudez, R. T., Camp, S. M., Hernon, V. R., Furenlid, L. R., et al. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.116103 · Cited by 15
Léger, L., Aliakbarshirazi, S., Zahedifar, P., Aalders, J., Voort, P. V. D., Geyter, N. D., Morent, R., van Hengel, J., & Ghobeira, R. (2024) · Applied Surface Science · doi:10.1016/j.apsusc.2024.159680 · Cited by 18
Use machine learning models to identify and assess risk factors for coronary artery disease
Zhang, M., Wang, H., & Zhao, J. (2024) · PLoS ONE · doi:10.1371/journal.pone.0307952 · Cited by 14
Sohail, M. U., Aisha, E., Waqas, S. A., Saad, M., Arshad, M. S., Ahmed, A. B., Sohail, M. O., Naveed, Z., Amin, E., Arora, S. M. S., et al. (2025) · Future Cardiology · doi:10.1080/14796678.2025.2490397 · Cited by 15
Yildirim, A., Grant, J. C., Es‐haghi, S. S., Lee, W., Maruthamuthu, M. K., Verma, M. S., Sutherland, J. W., & Çakmak, M. (2020) · Advanced Materials Technologies · doi:10.1002/admt.202000553 · Cited by 14
Feng, Y., Yu, Y., Tian, S., Zhou, Y., Chen, X., Ye, J., Liu, Q., Xu, X., Zhou, H., & Zhang, W. (2020) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2020.113460 · Cited by 14
Loika, Y., Feng, F., Loiko, E., & Kulminski, A. M. (2021) · GeroScience · doi:10.1007/s11357-021-00458-3 · Cited by 13
Zargarzadeh, N., Severo, J. S., Pizarro, A. B., Persad, E., & Mousavi, S. M. (2021) · Clinical Therapeutics · doi:10.1016/j.clinthera.2021.10.002 · Cited by 15
Specific characteristics of STEMI in COVID-19 patients and their practical implications
Gitto, M., Novelli, L., Reimers, B., Condorelli, G., & Stefanini, G. G. (2022) · Kardiologia Polska · doi:10.33963/kp.a2022.0072 · Cited by 16
Self-citationAsri, A. K., Pan, W., Lee, H., Su, H.-J. J., Wu, C., & Spengler, J. D. (2021) · Scientific Reports · doi:10.1038/s41598-021-84435-y · Cited by 15
Continuous 3D Myocardial Motion Tracking via Echocardiography
Shen, C., Zhu, H., Zhou, Y., Liu, Y., Si, Y., Dong, L., Zhao, W., Brady, D. J., Cao, X., Ma, Z., et al. (2024) · IEEE Transactions on Medical Imaging · doi:10.1109/tmi.2024.3419780 · Cited by 13
Wang, H., Xiu, M., Yang, F., Zhang, M., Wang, C., Wang, Q., Cheng, Y., Liu, X., & Zhang, W. (2025) · BMC Cardiovascular Disorders · doi:10.1186/s12872-025-04996-y · Cited by 14
Kumar, R., Bhargava, P., Suchal, K., Bhatia, J., & Arya, D. S. (2021) · Drug Development Research · doi:10.1002/ddr.21779 · Cited by 13
Treatment of Hypertension by Using Natural Herbs and their Mechanism of Action
Aloufi, B. H., Atwan, M. A., & Alshammari, A. M. (2022) · Journal Of Biochemical Technology · doi:10.51847/wx7mn3flrc · Cited by 13
Vasić, A., Vasiljević, Z., Mickovski-Katalina, N., Mandić‐Rajčević, S., & Soldatović, I. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph192114457 · Cited by 13
Mohajeri, M., & Cicero, A. F. G. (2023) · Nutrients · doi:10.3390/nu15030738 · Cited by 13
“Deaths caused by cardiovascular diseases in developed countries are decreasing in recent years due to preventive measures and effective interventions [3,4], while these cases are high in developing countries [5].”
BackgroundMazeli, M. I., Pahrol, M. A., Shakor, A. S. A., Kanniah, K. D., & Omar, M. A. (2023) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2023.162130 · Cited by 16
Platelet-Rich Plasma in Young and Elderly Humans Exhibits a Different Proteomic Profile
Jiang, Z., Huang, C., Guo, E., Zhu, X., Li, N., Huang, Y., Wang, P., Shan, H., Yin, Y., Wang, H., et al. (2024) · Journal of Proteome Research · doi:10.1021/acs.jproteome.4c00030 · Cited by 17
Wu, J. J., Way, J. A. H., & Brieger, D. B. (2019) · Heart International · doi:10.17925/hi.2019.13.2.17 · Cited by 13
“Coronary artery disease (CAD) is a major global cause of death attributing to nearly 9 million deaths worldwide in 2016.(1) The introduction of percutaneous coronary intervention (PCI) has revolutionised the treatment of CAD in current clinical practice, and advances in coronary stent technology have continued to deli…”
BackgroundTemporal trends in cardiovascular risk factors’ prevalence in patients with myocardial infarction
Çimci, M., Witassek, F., Radovanović, D., Rickli, H., Pedrazzini, G. B., Erné, P., Müller, O., Eberli, F. R., & Roffi, M. (2020) · European Journal of Clinical Investigation · doi:10.1111/eci.13466 · Cited by 13
Laundos, T. L., Vasques‐Nóvoa, F., Gomes, R. N., Sampaio‐Pinto, V., Cruz, P. E., Cruz, H. J., Santos, J. M., Bárcia, R. N., Pinto‐do‐Ó, P., & Nascimento, D. S. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.624601 · Cited by 13
“, 2019), with ischemic heart disease representing the largest single cause of death in countries of all income levels (Nowbar et al., 2019).”
BackgroundZicola, E., Arrigo, E., & Mancardi, D. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/8886666 · Cited by 13
Facilitators and barriers to return to work in patients after heart surgery
Pourhabib, A., Sabzi, Z., Yazdi, K., Fotokian, Z., & Riahi, G. A. (2022) · Journal of Education and Health Promotion · doi:10.4103/jehp.jehp_70_22 · Cited by 13
Sport in ischemic heart disease: Focus on primary and secondary prevention
Romano, S., Minardi, S., Patrizi, G., Palamà, Z., & Sciahbasi, A. (2023) · Clinical Cardiology · doi:10.1002/clc.24052 · Cited by 15
SHUFELT, C. L., Kim, A., Joung, S. Y., Barsky, L. L., Arnold, C. W., Cheng, S. C., Dhawan, S., Fuller, G., Speier, W. F., Lopez, M., et al. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.120.016023 · Cited by 13
The need for polygenic score reporting standards in evidence-based practice: lipid genetics use case
Wand, H., Knowles, J. W., & Clarke, S. L. (2021) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000733 · Cited by 13
“Atherosclerotic cardiovascular disease (ASCVD) is the leading cause of death in most nations [1,2].”
BackgroundDeep learning applications in coronary anatomy imaging: a systematic review and meta-analysis
Alskaf, E., Dutta, U., Scannell, C. M., & Chiribiri, A. (2022) · Journal of Medical Artificial Intelligence · doi:10.21037/jmai-22-36 · Cited by 12
Kotronias, R. A., Marin, F., Emfietzoglou, M., Langrish, J. P., Lucking, A. J., Channon, K. M., BANNING, A. P., & Maria, G. L. D. (2023) · Cardiovascular revascularization medicine · doi:10.1016/j.carrev.2023.02.012 · Cited by 12
Wang, M. T., Chao, C., Mei, K., Di, D., Qian, Y., Wang, B., & Zhang, X. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1099861 · Cited by 12
“High BMI, diabetes mellitus (DM), hypertension, high cholesterol level, and smoking are some of the various risk factors involved (3).”
BackgroundThe Association of Infection with Delirium in the Post-Operative Period after Elective CABG Surgery
Żukowska, A., Kaczmarczyk, M., Listewnik, M. J., & Żukowski, M. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12144736 · Cited by 12
“2 million deaths in Europe and more than 9 million deaths globally [2].”
BackgroundBoxhammer, E., Paar, V., Wernly, B., Kiss, A., Mirna, M., Aigner, A. M., Acar, E., Watzinger, S., Podesser, B. K., Zauner, R., et al. (2023) · Cells · doi:10.3390/cells12192369 · Cited by 12
“Ischemic cardiomyopathy (CMP) after acute myocardial infarction (MI) is the most common cause of heart failure and therefore the leading cause of death worldwide [1,2].”
BackgroundSpatiotemporal signaling underlies progressive vascular rarefaction in myocardial infarction
Tung, L. W., Groppa, E., Soliman, H., Lin, B., Chang, C.-K., Cheung, C. W., Ritso, M., Guo, D., Rempel, L., Sinha, S., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-44227-6 · Cited by 12
Rodríguez-Soto, M. A., Riveros, A., Orjuela-Garzón, I. C., Fernández-Calderón, I. M., Rodríguez, C. F., Vargas, N. S., Ostos, C., Muñoz-Camargo, C., Cruz, J. C., Kim, S., et al. (2024) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2024.1410863 · Cited by 12
Święczkowski, M., Lip, G. Y. H., Abohashem, S., Jemielita, P., Kurasz, A., Duzinkiewicz, M., Januszko, T., Tomaszuk−Kazberuk, A., Dobrzycki, S., & Kuźma, Ł. (2025) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwaf534 · Cited by 12
Zhou, X., Ruan, W., Jie, H., Liu, H., Wang, T., Li, J., Lin, K., & Lin, J. (2025) · Global Heart · doi:10.5334/gh.1486 · Cited by 14
Screening of Ischemic Heart Disease based on PPG Signals using Machine Learning Techniques
Pal, P., Ghosh, S. K., Chattopadhyay, B. P., Saha, K. K., & Mahadevappa, M. (2020) · Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC) · doi:10.1109/embc44109.2020.9176447 · Cited by 12
Temporal Course of Plasma Trimethylamine N-Oxide (TMAO) Levels in ST-Elevation Myocardial Infarction
Almesned, M. A., Prins, F. M., Lipšic, E., Connelly, M. A., Garcia, E., Dullaart, R. P. F., Groot, H. E., & van der Harst, P. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10235677 · Cited by 12
Stehli, J., Dagan, M., Dinh, D. T., Lefkovits, J., Dick, R., Oxley, S., Brennan, A., Duffy, S. J., & Zaman, S. J. (2022) · BMJ Open · doi:10.1136/bmjopen-2021-052000 · Cited by 12
Design and Development of a Hospital‐Based Coronary Artery Disease (CAD) Registry in Iran
Garavand, A., Rabiei, R., & Emami, H. (2023) · BioMed Research International · doi:10.1155/2023/3075489 · Cited by 12
Targeting Cardiac Metabolic Pathways: A Role in Ischemic Management
Yehualashet, A. S., Belachew, T. F., Kifle, Z. D., & Abebe, A. M. (2020) · Vascular Health and Risk Management · doi:10.2147/vhrm.s264130 · Cited by 13
Park, N., Marquez, J. C., Garcia, M. V. F., Shimizu, I., Lee, S. R., Kim, H. K., & Han, J. (2021) · Journal of Lipid and Atherosclerosis · doi:10.12997/jla.2021.10.2.223 · Cited by 12
Nnate, D. A., Eleazu, C. O., & Abaraogu, U. O. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19010211 · Cited by 13
PTMA controls cardiomyocyte proliferation and cardiac repair by enhancing STAT3 acetylation
Liu, N., Pei, J., Xie, Y., He, X., Jiang, N., Wang, J., Gao, Y., Li, Y., Li, X., Liu, W., et al. (2025) · Science Advances · doi:10.1126/sciadv.adt9446 · Cited by 11
Buck, K. M., Rogers, H. T., Gregorich, Z. R., Mann, M. W., Aballo, T. J., Gao, Z., Chapman, E. A., Perciaccante, A. J., Price, S. J., Lei, I., et al. (2025) · JCI Insight · doi:10.1172/jci.insight.196933 · Cited by 13
Blawas, A. M., Ware, K. E., Schmaltz, E., Zheng, L. Z., Spruance, J., Allen, A. S., West, N., Devos, N., Corcoran, D. L., Nowacek, D. P., et al. (2021) · Evolution Medicine and Public Health · doi:10.1093/emph/eoab036 · Cited by 11
Wei, D., Tang, L. M., Su, L., Zeng, S., Telushi, A., Lang, X., Zhang, Y., Qin, M., Qiu, L., Zhong, C., et al. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.1013013 · Cited by 11
“5 million cases of ischemic heart disease (IHD), with a concomitant of over 9 million deaths per year in the world, making IHD a leading cause of morbidity and mortality worldwide (3, 4).”
BackgroundAnti-Motion Interference Electrocardiograph Monitoring System: A Review
Shen, J., Li, X., Wang, Y., Li, Y., Bian, J., Zhu, X., He, X., & Li, J. (2024) · IEEE Sensors Journal · doi:10.1109/jsen.2024.3383872 · Cited by 13
The multifaceted role of autophagy and mitophagy in cardiovascular health and disease
Nàger, M., Calvoli, M., Larsen, K. B., & Birgisdottir, Å. B. (2025) · Autophagy Reports · doi:10.1080/27694127.2025.2572511 · Cited by 11
Stehli, J., Dinh, D. T., Dagan, M., Dick, R., Oxley, S., Brennan, A., Lefkovits, J., Duffy, S. J., & Zaman, S. J. (2022) · Clinical Cardiology · doi:10.1002/clc.23797 · Cited by 11
“Coronary artery disease is the leading cause of death worldwide.(1)”
BackgroundCheng, X., Zhang, R., Wei, S., Huang, J., Zhai, K., Li, Y., & Gao, B. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2022.900751 · Cited by 11
“Ischemic heart disease (IHD) is the leading cause of morbidity and mortality across the globe, accounting for 9 million deaths annually (1, 2).”
BackgroundPotus, F., Martin, A. Y., Snetsinger, B., & Archer, S. L. (2020) · Journal of Visualized Experiments · doi:10.3791/61088 · Cited by 11
Dutra, A. D. C., Silva, L. L., Pedroso, R. B., Tchuisseu, Y. P., da Silva, M. T., Bergamini, M., Scheidt, J. F. H. C., Iora, P. H., Franco, R. D. L., Staton, C. A., et al. (2021) · Global Heart · doi:10.5334/gh.770 · Cited by 11
Expedient assessment of post-infarct remodeling by native cardiac magnetic resonance imaging in mice
Lang, C. I., Vasudevan, P., Döring, P., Gäbel, R., Lemcke, H., Lindner, T., Steinhoff, G., Krause, B. J., Vollmar, B., Meinel, F. G., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-91096-4 · Cited by 11
Akboua, H., Eghbalzadeh, K., Keser, U., Wahlers, T., & Paunel‐Görgülü, A. (2021) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16915 · Cited by 11
A Bibliometric Analysis of Reactive Oxygen Species Based Nanotechnology for Cardiovascular Diseases
Liang, Y., Liao, S., & Zhang, X. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.940769 · Cited by 11
Immune checkpoint inhibitors – the revolutionary cancer immunotherapy comes with a cardiotoxic price
Achim, A., Liblik, K., & Gevaert, S. (2022) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2022.09.004 · Cited by 12
Ischemia promotes acyl-CoAs dephosphorylation and propionyl-CoA accumulation
He, W., Berthiaume, J. M., Previs, S. F., Kasumov, T., & Zhang, G. (2023) · Metabolomics · doi:10.1007/s11306-023-01975-2 · Cited by 11
Seidlmayer, L. K., Hanson, B. J., Thai, P. N., Schaefer, S., Bers, D. M., & Dedkova, E. N. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.628508 · Cited by 10
Koopman, M. Y., Reijnders, J. J. W., Willemsen, R. T. A., van Bruggen, R., Doggen, C. J. M., Kietselaer, B., Wolcherink, M. J. O., van Ooijen, P. M. A., Gratama, J. W., Braam, R. L., et al. (2022) · BMJ Open · doi:10.1136/bmjopen-2021-055123 · Cited by 10
Herranen, P., Koivunen, K., Palviainen, T., Kujala, U. M., Ripatti, S., Kaprio, J. A., Sillanpää, E., & FinnGen (2024) · The Journals of Gerontology Series A · doi:10.1093/gerona/glae064 · Cited by 13
Sagris, Μ., Theofilis, P., Mystakidi, V. C., Oikonomou, E. K., Tsioufis, K. P., & Tousoulis, D. (2024) · Hellenic Journal of Cardiology · doi:10.1016/j.hjc.2024.05.008 · Cited by 10
Cheng, Q., Sun, J., Zhong, H., Wang, Z., Liu, C., Zhou, S., & Deng, J. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1393333 · Cited by 15
Comparison of coronary CT angiography and invasive coronary angiography results
Tekinhatun, M., Akbudak, İ., Özbek, M., & Turmak, M. (2024) · Irish Journal of Medical Science (1971 -) · doi:10.1007/s11845-024-03745-y · Cited by 10
Jasim, A. A., Ata, O., & Salman, O. H. (2024) · International Journal of Medical Informatics · doi:10.1016/j.ijmedinf.2024.105608 · Cited by 12
Longitudinal Impacts of High Versus Low Greenness on Cardiovascular Disease Conditions
Brown, S. C., Aitken, W. W., Lombard, J. L., Parrish, A. K., Dewald, J. R., Nardi, M. I., Mantero, A. M. A., Metalonis, S. W., & Szapocznik, J. (2024) · Journal of the American Heart Association · doi:10.1161/jaha.123.029939 · Cited by 10
Hai, Y., Sakakura, K., Jinnouchi, H., Taniguchi, Y., Yamamoto, K., Tsukui, T., Hatori, M., Kasahara, T., Watanabe, Y., Ishibashi, S., et al. (2024) · Cardiovascular Intervention and Therapeutics · doi:10.1007/s12928-024-01075-5 · Cited by 10
Bondar, L. I., Iovanovici, D. C., Măduța, V., Butari, D. B., Șandor, F. M., Mariș, M. A., Piroș, L. E., Miuţa, C. C., Toderescu, C. D., & Popescu, M. I. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14030837 · Cited by 12
Zhang, S., Ding, S., Xu, Z., & Ye, J. (2025) · Frontiers in Artificial Intelligence · doi:10.3389/frai.2025.1686378 · Cited by 10
Anti-Apo B-100 Autoantibody is a Marker of Unstable Coronary Plaque
Imai, M., Kawamura, M., Kochi, I., Matsuoka, T., Kihara, S., & Yamamoto, H. (2020) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.58784 · Cited by 10
Mechanical Circulatory Support in High-Risk Percutaneous Coronary Intervention
Kunkel, K. J., Dabbagh, M. F., Zaidan, M., & Alaswad, K. (2021) · Interventional Cardiology Clinics · doi:10.1016/j.iccl.2020.12.002 · Cited by 10
“Coronary artery disease remains a leading worldwide cause of morbidity and mortality.(1) As medical and interventional therapies available to patients with atherosclerotic heart disease have improved, the number of patients surviving index coronary events has increased considerably.”
BackgroundNg, J. C. K., Toong, D. W. Y., Ow, V., Chaw, S. Y., Toh, H. W., Wong, P. E. H., Venkatraman, S. S., Chong, T. T., Tan, L. P., Huang, Y., et al. (2022) · Nanomedicine · doi:10.2217/nnm-2021-0288 · Cited by 10
Effects of swimming training on myocardial protection in rats
Lai, C., Tang, C., Fu, S., Tseng, W., & Tseng, K. (2022) · Biomedical Reports · doi:10.3892/br.2022.1502 · Cited by 10
Mild Cognitive impairment Occurs in Rats During the Early Remodeling Phase of Myocardial Infarction
Jinawong, K., Apaijai, N., Piamsiri, C., Maneechote, C., Arunsak, B., Chunchai, T., Pintana, H., Nawara, W., Chattipakorn, N., & Chattipakorn, S. C. (2022) · Neuroscience · doi:10.1016/j.neuroscience.2022.04.018 · Cited by 10
Low health literacy and quality of life in patients with systemic arterial hypertension
Cangussú, L. R., Alho, E. A. S., da Silva, A. L., da Fonsêca, D. V., Lopes, J. M., Barbosa, R. H. D. A., & Lopes, M. R. (2022) · Dialogues in Health · doi:10.1016/j.dialog.2022.100036 · Cited by 10
Aqeel, M. T., Rahman, N.-U., Khan, A., Khan, M. T., Ashraf, Z., Hassan, S. S. U., BUNGAU, S. G., & Majid, M. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115240 · Cited by 10
Federated Edge-Cloud Framework for Heart Disease Risk Prediction Using Blockchain
Ghosh, U., Das, D., Chatterjee, P., & Shillingford, N. (2023) · IFIP advances in information and communication technology · doi:10.1007/978-3-031-45882-8_21 · Cited by 10
Wang, R., Lu, D., Song, R., Du, L., Yang, X., Wu, S., Wang, X., Wong, J. J. L., Xu, Z., Zhao, Q., et al. (2023) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2023.09.004 · Cited by 10
The molecular mechanisms underlying gut microbiota-miRNA interaction in metabolic disorders
Prukpitikul, P., Sirivarasai, J., & Sutjarit, N. (2017) · Beneficial Microbes · doi:10.1163/18762891-20230103 · Cited by 10
Ding, Y., Chan, E. C., Liu, L., Liu, Z., Wang, Q., Wang, J., Cui, X., Jiang, F., & Guo, X. (2020) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.13375 · Cited by 10
Theodoropoulos, K. C., Vakalopoulou, S., Oikonomou, M., Stavropoulos, G., Ziakas, A., Kanonidis, I. E., & Kassimis, G. (2021) · Medicina · doi:10.3390/medicina57040352 · Cited by 10
Identification of metabolic pathways underlying FGF1 and CHIR99021-mediated cardioprotection
Xu, B., Li, F., Zhang, W., Su, Y., Tang, L. Y., Li, P., Joshi, J., Yang, A., Li, D., Wang, Z., et al. (2022) · iScience · doi:10.1016/j.isci.2022.104447 · Cited by 10
Nishiyama, H., Funamizu, T., Iwata, H., Endo, H., Chikata, Y., Doi, S., Wada, H., Naito, R., Ogita, M., Kato, Y., et al. (2022) · International Journal of Cancer · doi:10.1002/ijc.34164 · Cited by 9
Yang, L., Zheng, B., & Gong, Y. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5212269 · Cited by 10
Xie, P., Li, X., Guo, F., Zhang, D. “., & Zhang, H. (2023) · Frontiers in Public Health · doi:10.3389/fpubh.2023.1146914 · Cited by 9
“According to the Global Burden of Disease, Injuries, and Risk Factors Study 2019, there were an estimated 197 million prevalent cases of IHD globally in 2019 (2), making it the leading cause of mortality globally (3).”
BackgroundMethodResultSiriyotha, S., Pattanaprateep, O., Srimahachota, S., Sansanayudh, N., Thakkinstian, A., & Limpijankit, T. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1260993 · Cited by 9
Doom, J. R., Deer, L. K., Dabelea, D., LeBourgeois, M. K., Lumeng, J. C., Martin, C. K., Hankin, B. L., & Davis, E. P. (2024) · Developmental Psychology · doi:10.1037/dev0001704 · Cited by 12
Gupta, M. D., Batra, V., Muduli, S. K., Girish, M. P., Kunal, S., Bansal, A., Gautam, A., Malhotra, R. K., Goyal, D., Qamar, A., et al. (2024) · Indian Heart Journal · doi:10.1016/j.ihj.2024.04.002 · Cited by 10
Jin, S., Xia, K., Sun, B., Xie, L., & Zhang, H. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1384023 · Cited by 9
Aziz, S., Akhlaq, A., Owings, A. H., Gurz, S., Zafar, Y., Ali, B., & Tang, S. (2024) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izae184 · Cited by 9
Tang, J., Hu, S., Liu, X., Li, H., Kuang, L., Zhang, L., Cao, W., Zhang, T., Xiaoyan, G., Li, L., et al. (2024) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2024.1396380 · Cited by 9
Mitophagy is induced in human engineered heart tissue after simulated ischemia and reperfusion
Nàger, M., Larsen, K. B., Bhujabal, Z., Kalstad, T., Rössinger, J., Myrmel, T., Weinberger, F., & Birgisdottir, Å. B. (2025) · Journal of Cell Science · doi:10.1242/jcs.263408 · Cited by 10
Schwab, M. G., Pamminger, M., Kremser, C., Haltmeier, M., & Mayr, A. (2025) · Radiology Advances · doi:10.1093/radadv/umaf023 · Cited by 9
“1,2 3–6 However, obtaining these important predictors requires segmentation of late gadolinium enhancement (LGE) cardiovascular magnetic resonance (CMR) images.”
Yang, X., Zhang, J., Song, Y., Jia, D., Hong, Q., Zhan, Y., Zhou, X. S., Dong, Y., Wang, Y., Wu, D., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-64940-8 · Cited by 9
Metadata
- Authors
- Nowbar, A. N., Gitto, M., Howard, J. P., Francis, D. P., & Al-Lamee, R.
- Affiliations
- Hammersmith Hospital (GB)
- International Centre for Circulatory Health, National Heart and Lung Institute, Imperial College London, Hammersmith Hospital, London, United Kingdom (A.N.N., M.G., J.P.H., D.P.F., R.A.-L.).
- Corresponding author
- Nowbar, Alexandra N.
- Venue
- Circulation: Cardiovascular Quality and Outcomes
- Published
- 2019-06
- Volume
- 12
- Issue
- 6
- Pages
- e005375-e005375
- ISSN
- 1941-7705 (ISSN-L)
- 1941-7713
- PMC
- PMC6613716
- OpenAlex
- W2950663303
- Cited by
- 860
- References
- 20
- Citations by year
- 2026: 58 · 2025: 121 · 2024: 149 · 2023: 155 · 2022: 147 · 2021: 133 · 2020: 83 · 2019: 12
- FWCI
- 71.55
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- Locations
- Circulation Cardiovascular Quality and Outcomes (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Spiral (Imperial College London) (submittedVersion, cc-by)
- Funders
- Wellcome Trust (212183/Z/18/Z)
- National Institute for Health and Care Research
- Topics
- Health Sciences › Medicine › Epidemiology › Healthcare Systems and Public Health
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Risk Factors
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Global Health and Epidemiology
- Keywords
- ischemic heart disease, mortality trends, age-standardized mortality rates, non-communicable diseases, lung cancer, stroke, cardiovascular risk factors, smoking, hypertension, obesity, type 2 diabetes, income inequality, sex differences, global burden of disease
- MeSH terms
- Adult, Aged, Aged, 80 and over, Cause of Death, Diabetes Mellitus, Female, Humans, Hypertension, Male, Middle Aged, Obesity, Risk Factors, Smoking, Time Factors, Global Health, World Health Organization, Comorbidity, Prevalence, Myocardial Ischemia, Age Distribution, Sex Distribution, Risk Assessment, Health Status Disparities
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review